ANDA 60760, held by Impax Laboratories. Oxytetracycline Hydrochloride.
As of Nov 21, 2026, ANDA 60760 (Oxytetracycline Hydrochloride), held by Impax Laboratories, was first approved by FDA on Aug 9, 1967, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 9, 1967 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Oxytetracycline HydrochlorideEQ 250MG BASE · capsule;oral | Oxytetracycline Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters